Reported Issues: Consumers report: That the supplement did not lead to weight loss or appetite suppression as advertised That the product was marketed using misleading claims about GLP-1 support That they paid for a product that did not provide the promised benefits That the supplements are promoted as alternatives to GLP-1 medications, despite not functioning like prescription GLP-1 drugs That marketing materials imply that these supplements are scientifically and medically proven and reliable, when evidence may be lacking That they would not have purchased the supplements if they had known the claims were not supported by reliable scientific evidence Experiencing adverse side effects such as stomach pain, bloating, or skin rashes Why Individuals Should Be Concerned: Potential claims include: Economic loss False advertising Safety risk Product defect Performance vs

The mechanisms of action of GLP-1R in DM and AD overlap, which suggests that GLP-1R may be a bridge between these two diseases
What a great experience
Similar data were presented by La Rubia et al., Abdulnasser et al., and Shukla et al., who observed that serum copper, manganese, and aluminum concentration were significantly higher in fibromyalgia patients than in healthy controls
This increases glucosedependent insulin secretion, decreases glucagon, slows gastric emptying, and activates satiety centers in the hypothalamus, leading to reduced hunger, smaller portions, and improved postmeal glucose control